H uman papillomavirus (HPV) vaccines prevent infection with 2 types of HPV that account for 70% of cervical cancer cases; one of the vaccines (HPV4) prevents infection with 2 additional types that account for 90% of cases of genital warts. Because HPV vaccination provides maximum protection if administered before sexual debut, HPV4 guidelines recommend administering HPV4 for girls aged 11 and 12 years, with catch-up vaccination for females up to age 26, for the prevention of cervical cancer [1, 2] . Recently, guidelines expanded to include HPV2 for the prevention of cervical cancer in females aged 10 to 25 years and HPV4 for prevention of genital warts in males aged 9 to 26 years [3, 4] . Our study occurred when only HPV4 was available for females.
Studies of factors associated with HPV vaccine acceptability and completion rates have rapidly grown in number [5, 6] , but these investigations have generally relied on survey items that have undergone limited testing for understandability. A recent systematic review of survey items addressing HPV vaccine acceptability found that only 32% (25/79) of studies conducted between 1995 and early 2009 provided any reliability or validity information on their measures. Only 2 studies held focus groups to improve the content validity of survey items, and none reported cognitive testing of survey items [7] .
National studies including the Health Information National Trends Survey, National Health Interview Survey, Behavioral Risk Factor Surveillance System, and National Immunization Survey have tested survey items on HPV knowledge and HPV vaccination intentions and behavior, but they have not typically published the results of these evaluations [8, 9] . In addition, these population-based studies have focused on a narrow range of topics, mainly assessing vaccine acceptability and factors associated with the completion of the 3-dose vaccination series. As studies investigating factors associated with HPV vaccine acceptability and completion may serve as the foundation for future vaccine promotion interventions, it is crucial that survey items are well tested to ensure that study findings yield meaningful results.
One approach is to use cognitive testing, also called cognitive interviewing, which is a group of methods to evaluate and improve survey items and design through understanding how people come up with answers to survey questions [10Y14]. Cognitive interviewing methods can reconcile survey items' intended and actual interpretations, potentially providing more valid and reliable measures [15] . Two commonly used cognitive interviewing techniques are verbal probing and ''think aloud'' [13] . In verbal probing, participants answer questions about their interpretations of a survey item, paraphrase it, or define a phrase or word used in a survey item. In ''think aloud,'' participants verbalize ideas that come to mind as they answer a question and thereby shed light on reactions, inferences, and beliefs that helped them arrive at their answer. Both techniques are useful in identifying problems with survey item wording and design.
The purpose of this study was to develop a set of survey items that would be useful for a broad range of behavioral scientists. We specifically wanted to test survey items that assess constructs previously associated with HPV vaccine acceptability and completion. A work group of investigators from the multicenter Cancer Prevention and Control Research Network cognitively tested survey items intended for parents of daughters who were age-eligible to receive the HPV vaccine. To our knowledge, this is the first published study of cognitive testing of such survey measures.
METHODS

Participants
Study participants were a purposive sample of 62 racially and ethnically diverse parents or primary caretakers of adolescent females aged 9 to 17 years recruited from a variety of community settings, including community centers, health clinics, and churches by researchers at the 6 centers across the United States. We did not recruit parents of adolescent males because guidelines at the time of the study did not support providing HPV vaccine to males. Other eligibility criteria were speaking English and being involved in decision making about their daughters' health care. Although we interviewed both parents and primary caretakers of adolescent girls, we refer to them as parents for the remainder of the article for the sake of simplicity. We chose the age range of 9 to 17 years because the US Food and Drug Administration permits HPV vaccination beginning at age 9, and women aged 18 years and older are adults who do not need parental permission to receive the vaccine.
Measures
The goal was to develop a set of survey items that would be useful for a broad range of behavioral scientists. For this reason, we identified relevant constructs from health behavior theories (including the health belief model and the theory of planned behavior) [16Y18] and the empirical literature that were associated with HPV vaccine acceptability or completion [5] . We chose to focus on items related to cervical cancer and not HPV infection or genital warts because past research has shown that attitudes toward cancer are more closely related to HPV vaccine intentions [19, 20] . We eliminated constructs that national surveys such as Health Information National Trends Survey and Behavioral Risk Factor Surveillance System had already tested (measures of HPV vaccine willingness and intentions, HPV vaccine completion, and HPV knowledge) [8, 9] . Work group members voted to select a final list of constructs: information seeking, physician recommendation, decision self-efficacy, vaccination self-efficacy, perceived likelihood, perceived effectiveness (benefits), perceived effect of TV ads, injunctive social norms, attitudes toward mandates, perceived side effects, perceived barriers, vaccine concerns, and anticipated regret.
For each construct, work group members identified items from their own research, published articles, unpublished items from experts, and measurement considerations directed by theory, when available. The work group generated an initial list of constructs and refined the list based on input from behavioral scientists with expertise in HPV vaccine research. We then carried out a consensus development process where we created a final list by an initial vote confirmed by discussion to consensus during several meetings and decided on a final set of constructs. After another vote and discussion to consensus, the work group identified 20 survey items and further refined their wording, with a goal of increasing simplicity, clarity, and comprehension. We created 3 versions of the survey that rotated the main survey content to minimize the potential for response set bias.
The survey started with a brief definition of HPV, presented the 20 survey items for cognitive testing (see Appendix), and ended with basic demographic and background questions. For parents with more than 1 daughter aged 9 to 17 years, interviewers asked them to think of the daughter with the most recent birthday when answering the HPV vaccine questions. In-person interviews assessed health literacy using the Rapid Estimate of Adult Literacy in Medicine Short Form that categorizes individuals as ''at risk for poor health literacy'' or having ''adequate health literacy'' [21] .
Cognitive Interview Probes
Interviewers primarily used scripted semistructured probes, although interviewers could also use spontaneous probes when appropriate. We developed standard cognitive probes from ones commonly used in cognitive testing [14] . 
Procedures
Interviewers attended a training to ensure consistent interview and data collection procedures. The training provided in-depth instruction in cognitive interviewing as well as an orientation to the interview guide and protocol. Researchers at 5 centers conducted in-person interviews, and researchers at 1 center conducted both in-person and telephone interviews (1 center did not participate in the data collection phase of the study). One or two interviewers collected data at each center. Each of the 6 centers conducted between 5 and 20 cognitive interviews. We conducted 4 separate rounds of cognitive testing and item revision. A new sample of participants was recruited for each round of testing.
Interviewers met one-on-one in a closed room with parents for a 1-hour cognitive testing session that was audiorecorded. For in-person interviews, each parent received a copy of the survey to follow as the interviewer read the question and answer choices aloud. At the beginning of the session, the interviewer explained the study and briefly described how to ''think aloud.'' The interviewer read each question and response option aloud and then used both verbal probing and think-aloud techniques. Incentive for participation ranged from $20 to $50 depending on the center. Institutional review boards (IRBs) at each center approved the study protocol; the Centers for Disease Control and Prevention IRB relied on the investigators' home IRB approvals. Written informed consent was obtained from in-person interviews, and oral consent was obtained from telephone interviews.
Data Analysis
At each site, researchers listened to audiotapes and analyzed case notes taken during their interviews. On the basis of this analysis, each site investigator created a document with parents' responses to cognitive probes and an overall recommendation for modifications. We integrated these documents into 1 master document. Investigators and interviewers from all sites reviewed the master document and came to consensus on whether and how to modify each item. This process was repeated after each round of cognitive testing.
RESULTS
We conducted 58 interviews in person and 4 by telephone. Participants were racially and ethnically diverse and had a wide range of income, education, and literacy levels as shown in Table 1 .
The original and final items appear in Table 2 , with the full survey in the Appendix. To the initial 20 survey items, we added 1 item about having a discussion with a physician to clarify a series of items about physician recommendation, and we removed a perceived barriers item about having to talk with their daughter to get the vaccine owing to the lack of variation in responses. We revised 14 items based on findings from the cognitive interviews.
The initial wording of the decision making selfefficacy item confused some parents. It originally read, ''How sure are you that you can make an informed decision about getting your daughter the HPV vaccine?'' and had a 4-point response scale labeled ''very sure'' to ''very unsure.'' Parents better understood and accepted the revision, ''I have enough information to make a decision about getting my daughter the HPV vaccine,'' with a 4-point response scale labeled ''strongly agree'' to ''strongly disagree.'' Parents were reluctant to answer several items on perceived cervical cancer likelihood and perceived vaccine effectiveness because they felt they were being asked questions they did not know the answer to. To help them understand that we wanted their opinions, even if they were unsure, we added the clarifying instruction, ''If you don't know, make your best guess,'' to increase the responses. After additional rounds of testing, the item still yielded some answers of ''don't know,'' and thus we tested this new item in the last round of interviewing, ''I think the HPV vaccine would lower my daughter's chances of getting cervical cancerIa lot, a little, or not at all.'' However, because this item did not undergo the full process of cognitive testing as other items, this new item requires further testing.
The item assessing perceived effect of TV ads was unclear to some parents, because it used the word ''ads.'' Several parents spontaneously noted that ''commercials'' was more understandable than ''ads,'' and so we adopted the suggested wording. The item assessing information seeking that originally read, ''If you had a strong need to get information about the HPV vaccine, where would you go?'' led some parents to believe that we were only interested in urgent searches. It was changed to ''If you needed information about the HPV vaccine, where would you go?'' We revised the item to focus on routine searching for HPV vaccine information.
Some parents misunderstood several items about perceived side effects and vaccine concerns (e.g., vaccine causing health problems, daughter being too young for the vaccine) to be statements of fact, and some became concerned. We developed an introductory sentence to clarify that these were statements of opinion and also revised the items. For example, we added ''I think'' to the beginning of the item about daughters' age that originally read, ''My daughter is too young to get the HPV vaccine.'' These changes helped reduce parents' concerns that we were asking for facts rather than their opinions. Some parents were offended by our initial item designed to assess the concerns about vaccine cost that We revised the item to focus on routine searching for information.
Check all that apply. Next, please circle the place you would go first.
Physician recommendation V We added this item after starting cognitive testing because parents who had not spoken with their physicians about the HPV vaccine struggled with answering the physician recommendation questions. We made no changes to the item. Has your daughter's health care provider told you that she should NOT get the HPV vaccine?
Decision self-efficacy How sure are you that you can make an informed decision about getting your daughter the HPV vaccine? Some parents found the item confusing, in part because of the words ''how sure'' and ''informed decision.'' I have enough information to make a decision about getting my daughter the HPV vaccine.
We changed the item to a declarative statement and shifted its focus to being about having enough information.
Vaccination self-efficacy How sure are you that you could get the HPV vaccine for your daughter if you decided you wanted to?
No change.
How sure are you that you could get the HPV vaccine for your daughter if you decided you wanted to?
Perceived likelihood Without the HPV vaccine, what do you think is the chance your daughter will get cervical cancer in the future?
Some parents were reluctant to answer or were unsure of their answer.
Without the HPV vaccine, what do you think is the chance your daughter will get cervical cancer in the future? If you don't know, make your best guess.
We added instructions to give their ''best guess.''
Perceived effectiveness (benefits) In your opinion, how effective do you think the HPV vaccine is in preventing cervical cancer? Some parents were reluctant to answer or were unsure of their answer.
How effective do you think the HPV vaccine is in preventing cervical cancer?
If you don't know, make your best guess.
We settled on the item presented in the column to the right, but we acknowledge that, during additional rounds of testing, some parents still spontaneously answered ''don't know.'' When we tested the below item in the last round of testing between 2 parents who answered ''don't know,'' they had no problems with the item.
I think the HPV vaccine would lower my daughter's chances of getting cervical cancerI A lot A little Not at all An item like the one above may be more understandable to some parents, pending further testing.
Perceived effect of TV ads TV ads about the HPV vaccine made me want to learn more about it.
The word ''ads'' was confusing to some parents.
TV commercials about the HPV vaccine made me want to learn more about it.
We replaced it with ''commercials.''
Injunctive social norms My daughter's other parent would approve of her getting the HPV vaccine.
My daughter's other parent would approve of her getting the HPV vaccine.
Some parents had problems with the words ''other parent,'' but offered conflicting advice to more specifically refer to the biologic parent (father/mother) or to not refer to the biologic parent at all (for those parents who were not married and not involved with other parent). Despite these concerns, parents seemed to understand the item.
Injunctive social norms The opinion of my daughter's other parent would influence my decision to get her the HPV vaccine.
The opinion of my daughter's other parent would influence my decision to get her the HPV vaccine.
Attitudes toward mandates HPV vaccination should be required before 11-and 12-year-old girls can attend school as long as parents can opt out.
Parents did not understand ''opt out.''
As long as her parents agree, HPV vaccination should be required before an 11-or 12-year-old girl can start sixth grade.
We revised the item, but some parents still questioned why we were asking about this age range (11-and 12-year-olds).
We propose an item at right that requires additional testing.
V Some parents misunderstood the next 3 items to be factual statements and became concerned.
Some people think that the HPV vaccine may cause health problems. Others think that it only causes minor discomfort.
Please say whether you agree or disagree with the following statements.
We added the instructions at right to clarify that these items reflect opinions.
Perceived side effects Getting the HPV vaccine is very painful.
To make clearer that we were asking for an opinion, we added the words ''I think'' to this item.
I think getting the HPV vaccine would be very painful.
Perceived side effects If my daughter gets the HPV vaccine, it may cause health problems for her in the future.
Some parents were confused with the ''if-then'' phrasing of this item.
I am concerned the HPV vaccine may cause health problems for my daughter in the future.
We simplified the wording and changed to a declarative statement.
Perceived side effects Getting the HPV vaccine may cause problems getting pregnant later in life. To clarify that we were asking for an opinion, we added the words ''I am concerned.'' I am concerned that the HPV vaccine may cause my daughter problems getting pregnant later in life.
Perceived barriers The fact that there are 3 doses required for the HPV vaccine would keep me from getting it for my daughter.
The fact that there are 3 doses required for the HPV vaccine would keep me from getting it for my daughter.
We reversed the order of this item and the next, because parents thought we were asking whether 3 shots would be too expensive.
Perceived barriers Not being able to pay for the HPV vaccine would keep me from getting it for my daughter. Some parents said that the phrase ''not being able to pay'' was offensive, because it implied that they could not afford health care for their daughters.
The cost of the HPV vaccine would keep me from getting it for my daughter.
We changed the item to shift the emphasis to cost being a shortcoming of the vaccine.
Vaccine concerns My daughter is too young to get the HPV vaccine.
Some parents thought this item stated a fact.
I think my daughter is too young to get the HPV vaccine.
Vaccine concerns My daughter may be more likely to think it's okay to have sex if she gets the HPV vaccine.
Some parents found the item confusing.
Getting my daughter the HPV vaccine may make her think that it is okay to have sex.
We reworded the item.
Anticipated regret I would regret it if my daughter got an HPV infection that could lead to cervical cancer because I did not get her the HPV vaccine.
I would regret not getting my daughter the HPV vaccine if she later got an HPV infection that could lead to cervical cancer.
We clarified by rewording the item.
Perceived barriers Having to talk to my daughter about sex before getting the HPV vaccine would keep me from getting it for her.
Some parents found the item and response scale confusing.
V
We developed an introductory sentence to help explain the question and changed the strongly agree to strongly disagree response scale to a yes/no scale.
The revised wording read, ''Some people think that getting the HPV vaccine means that they would have to talk to their daughter about sex. Would this keep you from getting your daughter the HPV vaccine?'' We dropped the item because all parents interviewed answered no.
read, ''Not being able to pay for the HPV vaccine would keep me from getting it for my daughter.'' Many said this implied that they could not afford health care for their daughters. After we changed the item to read, ''The cost of the HPV vaccine would keep me from getting it for my daughter,'' parents found it acceptable.
CONCLUSIONS
Our study findings highlight the importance of cognitive interviewing as one way to identify discordance between survey item meaning intended by researchers and the meaning derived by respondents. An especially troublesome issue was that some parents interpreted items as assessing their knowledge when our intention was to assess their opinions. Adding clarifying sentences to remove the pressure of picking the ''right'' answer seemed to help. Some parents also misinterpreted hypothetical questions as fact, a problem that small changes to these items addressed. Other revisions included additional wording clarifications, addressing misinterpretation due to item order, and removing an item owing to a lack of variation in response. Cognitive interviewing allowed us to identify these problems and provided insight into potential solutions. Researchers are using cognitive testing more widely to enhance the quality of data collection instruments. Applications have included improving surveys assessing colorectal cancer screening use [22] and skin cancer prevention behaviors [23] . However, studies using ad hoc surveys on HPV vaccine beliefs have not typically reported having used cognitive testing [7] . The only published standardized HPV vaccine beliefs scale we are aware of, the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) [24] , made use of limited cognitive testing but did not report it. This study used some similar items from the CHIAS such as items measuring perceived effectiveness, barriers, and vaccine concerns. Our results can help improve the wording of some items from the CHIAS.
To our knowledge, this is the first published study to document cognitive testing of HPV vaccine survey items. Although cognitive testing is often only done with 1 revision and test phase, we cognitively tested items through a series of phases by initially testing the items with a small sample of parents, using feedback to revise items and readminister to a new sample of parents 4 times. This iterative process allowed us to identify new problems that arose as we modified items. The larger sample size allowed us to identify less common but still important problems with survey items. We made most changes in response to findings of the first 2 rounds of testing, indicating that the largest benefit of cognitive testing occurs early on. Being able to conduct cognitive testing with a small number of participants (perhaps 6Y8, as is often recommended) [14] may make cognitive testing more feasible for investigators initiating HPV studies. Other strengths of our study include the collaboration of 7 centers in the United States, which brought together a group of experienced investigators and allowed us to include participants from geographically and ethnically diverse populations and to broaden the generalizability of our survey items.
Although some might consider the study's convenience sampling method a limitation, representative sampling typically is not a primary goal of cognitive interviewing specifically or qualitative research in general. More commonly, one seeks to maximize variation in a sample by including respondents across strata of a given characteristic that matches characteristics of the intended participants in the main study, the approach we took. We tested these items extensively in-person and to a lesser extent over the telephone, but additional testing may be necessary for studies using different interview modes (e.g., online surveys). It was not feasible in the context of this study to test items in multiple languages, and therefore, our findings reflect responses among only English-speaking individuals. We recommend translation and testing among nonEnglish-speaking individuals before using the survey in languages other than English, and it is currently being tested in Spanish now. Another important next step in this work would be to examine the psychometric characteristics of our survey items, such as internal consistency reliability and convergent validity, and to examine the performance of these items in nonYEnglishspeaking populations.
This study used cognitive interviewing across a geographically, ethnically, and educationally diverse population to provide a set of cognitively tested survey measures on the HPV vaccine. It is important to maximize correspondence between researchers' and participants' understanding of survey items and minimize error to generate the most accurate findings. Using cognitive testing in an integrated strategy for instrument development can identify problems with measures early on. Future studies should also consider pairing qualitative approaches such as cognitive testing with quantitative approaches to establish construct validity such as assessing convergent and discriminant validity.
